Tests for Latent Tuberculosis in People With ESRD: A Systematic Review

Mack, 2009, LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis?, Eur Respir J, 33, 956, 10.1183/09031936.00120908 Cengiz, 1996, Increased incidence of tuberculosis in patients undergoing hemodialysis, Nephron, 73, 421, 10.1159/000189104 Hussein, 2003, Tuberculosis and chronic renal disease, Semin Dial, 16, 38, 10.1046/j.1525-139X.2003.03010.x Dobler, 2011, Risk of tuberculosis in dialysis patients: a nationwide cohort study, PLoS ONE, 6, e29563, 10.1371/journal.pone.0029563 Jasmer, 2002, Clinical practice, N Engl J Med, 347, 1860, 10.1056/NEJMcp021045 Blumberg, 2003, American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis, Am J Respir Crit Care Med, 167, 603, 10.1164/rccm.167.4.603 Sousa, 2008, Pharmacokinetics and pharmacodynamics of drug interactions involving rifampicin, rifabutin and antimalarial drugs, J Antimicrob Chemother, 62, 872, 10.1093/jac/dkn330 Niemi, 2003, Pharmacokinetic interactions with rifampicin: clinical relevance, Clin Pharmacokinet, 42, 819, 10.2165/00003088-200342090-00003 Thompson, 1995, Anti-tuberculosis medication and the liver: dangers and recommendations in management, Eur Respir J, 8, 1384, 10.1183/09031936.95.08081384 Sester, 2004, Tuberculin skin testing underestimates a high prevalence of latent tuberculosis infection in hemodialysis patients, Kidney Int, 65, 1826, 10.1111/j.1523-1755.2004.00586.x Segall, 2010, Diagnosis of tuberculosis in dialysis patients: current strategy, Clin J Am Soc Nephrol, 5, 1114, 10.2215/CJN.09231209 Denkinger, 2011, Guidelines on interferon-gamma release assays for tuberculosis infection: concordance, discordance or confusion?, Clin Microbiol Infect, 17, 806, 10.1111/j.1469-0691.2011.03555.x Mazurek, 2010, Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection—United States, 2010, MMWR Recomm Rep, 59, 1 2008, Updated recommendations on interferon gamma release assays for latent tuberculosis infection, Can Commun Dis Rep, 34, 1 2011 2010, Guidelines for the prevention and management of Mycobacterium tuberculosis infection and disease in adult patients with chronic kidney disease, Thorax, 65, 557, 10.1136/thx.2010.144295 2007 2011 Pai, 2004, Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review, Lancet Infect Dis, 4, 761, 10.1016/S1473-3099(04)01206-X Pai, 2008, Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update, Ann Intern Med, 149, 177, 10.7326/0003-4819-149-3-200808050-00241 Chang, 2010, Systematic review of interferon-gamma release assays in tuberculosis: focus on likelihood ratios, Thorax, 65, 271, 10.1136/thx.2009.126771 Dinnes, 2007, A systematic review of rapid diagnostic tests for the detection of tuberculosis infection, Health Technol Assess, 11, 1, 10.3310/hta11030 Whiting, 2003, The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews, BMC Med Res Methodol, 3, 25, 10.1186/1471-2288-3-25 Agresti, 1996 2010 Linquist, 2002, Tuberculosis exposure of patients and staff in an outpatient hemodialysis unit, Am J Infect Control, 30, 307, 10.1067/mic.2002.123394 Hickstein, 2004, Tuberculosis transmission in a renal dialysis center—Nevada, 2003, MMWR Morb Mortal Wkly Rep, 53, 873 Inoue, 2009, The value of QuantiFERON TB-Gold in the diagnosis of tuberculosis among dialysis patients, Nephrol Dial Transplant, 24, 2252, 10.1093/ndt/gfp030 Lee, 2010, High prevalence of latent tuberculosis infection in dialysis patients using the interferon- release assay and tuberculin skin test, Clin J Am Soc Nephrol, 5, 1451, 10.2215/CJN.01790210 Lee S, Chou KJ, Su IJ, et al. High prevalence of latent tuberculosis infection in end-stage renal disease patients on hemodialysis, using QuantiFERON-GOLD In-Tube Test and tuberculin skin test. Paper presented at: 49th Interscience Conference on Antimicrobial Chemotherapy. September 12-15, 2009; San Francisco, CA. Seyhan, 2010, Comparison of the QuantiFERON-TB Gold In-Tube test with the tuberculin skin test for detecting latent tuberculosis infection in hemodialysis patients, Transplant Infect Dis, 12, 98, 10.1111/j.1399-3062.2009.00469.x Kim, 2010, Diagnostic usefulness of a T cell-based assay for latent tuberculosis infection in kidney transplant candidates before transplantation, Transplant Infect Dis, 12, 113, 10.1111/j.1399-3062.2010.00495.x Kim S, Lee S, Park I, et al. A prospective longitudinal study of usefulness of a T cell-based assay for latent tuberculosis infection (LTBI) in renal transplant recipients. Paper presented at: 48th Meeting of the Infectious Diseases Society of America. October 21-24, 2010; Vacouver, BC. Chung, 2010, Serial testing of interferon-gamma-release assays for the diagnosis of latent tuberculosis in hemodialysis patients, J Infect, 61, 144, 10.1016/j.jinf.2010.04.010 Triverio, 2009, Interferon-gamma release assays versus tuberculin skin testing for detection of latent tuberculosis in chronic haemodialysis patients, Nephrol Dial Transplant, 24, 1952, 10.1093/ndt/gfn748 Lee, 2009, High prevalence of latent tuberculosis infection in patients in end-stage renal disease on hemodialysis: comparison of QuantiFERON-TB GOLD, ELISPOT, and tuberculin skin test, Infection, 37, 96, 10.1007/s15010-008-8082-3 Lee S, Ni Y, Huang T, et al. QuantiFERON-TB GOLD for diagnosis of latent tuberculosis infection in patients with end-stage renal disease in Taiwan. Paper presented at: 46th Interscience Conference on Antimicrobial Chemotherapy. September 27-30, 2006; San Francisco, CA. Eleftheriadis, 2005, The value of serum antilipoarabinomannan antibody detection in the diagnosis of latent tuberculosis in hemodialysis patients, Am J Kidney Dis, 46, 706, 10.1053/j.ajkd.2005.06.021 Yanai, 2006, Evaluation of serological diagnosis tests for tuberculosis in hemodialysis patients, Ther Apher Dial, 10, 278, 10.1111/j.1744-9987.2006.00381.x Wauters, 2004, The value of tuberculin skin testing in haemodialysis patients, Nephrol Dial Transplant, 19, 433, 10.1093/ndt/gfg569 Shankar, 2005, The prevalence of tuberculin sensitivity and anergy in chronic renal failure in an endemic area: tuberculin test and the risk of post-transplant tuberculosis, Nephrol Dial Transplant, 20, 2720, 10.1093/ndt/gfi141 Fang, 2002, Tuberculin skin test and anergy in dialysis patients of a tuberculosis-endemic area, Nephron, 91, 682, 10.1159/000065031 Yildiz, 1998, Tuberculin responsiveness in hemodialysis patients, Chest, 114, 947, 10.1378/chest.114.3.947-b Yildiz, 1997, Tuberculin (PPD) reactivity in hemodiaylsis patients (HDp), Nephrol DialTransplant, 12, A148 Ates, 2010, Incidence of tuberculosis disease and latent tuberculosis infection in patients with end stage renal disease in an endemic region, Ren Fail, 32, 91, 10.3109/08860220903367528 Ates, 2009, Comparison of interferon-gamma release assay versus tuberculin skin test for latent tuberculosis screening in hemodialysis patients, Biotechnol Biotechnol Equip, 23, 1242, 10.1080/13102818.2009.10817646 Habesoglu, 2007, Value of the tuberculin skin test in screening for tuberculosis in dialysis patients, Transplant Proc, 39, 883, 10.1016/j.transproceed.2007.02.035 Taskapan, 2000, Tuberculin and anergy testing in CAPD patients, Perit Dial Int, 20, 807, 10.1177/089686080002000647 Dogan, 2005, Tuberculin skin test results and the booster phenomenon in two-step tuberculin skin testing in hemodialysis patients, Ren Fail, 27, 425, 10.1081/JDI-200065379 Cengiz, 2006, Boosted tuberculin skin testing in hemodialysis patients, Am J Infect Control, 34, 383, 10.1016/j.ajic.2005.12.003 Woeltje, 1998, Tuberculosis infection and anergy in hemodialysis patients, Am J Kidney Dis, 31, 848, 10.1016/S0272-6386(98)70055-1 Smirnoff, 1998, Tuberculin and anergy skin testing of patients receiving long-term hemodialysis, Chest, 113, 25, 10.1378/chest.113.1.25 Poduval, 2003, Tuberculosis screening in dialysis patients—is the tuberculin test effective?, Clin Nephrol, 59, 436, 10.5414/CNP59436 Sester, 2006, Improved efficiency in detecting cellular immunity towards M. tuberculosis in patients receiving immunosuppressive drug therapy, Nephrol Dial Transplant, 21, 3258, 10.1093/ndt/gfl416 Sester, 2009, Impaired detection of Mycobacterium tuberculosis immunity in patients using high levels of immunosuppressive drugs, Eur Respir J, 34, 702, 10.1183/09031936.00013409 Passalent, 2007, Detecting latent tuberculosis infection in hemodialysis patients: a head-to-head comparison of the T-SPOT.TB test, tuberculin skin test, and an expert physician panel, Clin J Am Soc Nephrol, 2, 68, 10.2215/CJN.01280406 Winthrop, 2008, Interferon-gamma release assays for diagnosing Mycobacterium tuberculosis infection in renal dialysis patients, Clin J Am Soc Nephrol, 3, 1357, 10.2215/CJN.01010208 Kantarci, 2006, Tuberculin positivity: a serious problem before transplantation in Turkey, Transplant Proc, 38, 646, 10.1016/j.transproceed.2006.02.008 Aydogan, 2009, [Tuberculin skin test reactivity in patients with chronic renal failure] [in Turkish], Tuberk Toraks, 57, 268 Basoglu, 2006, [T-lymphocyte subgroups and tuberculin skin test reactivity in patients with chronic renal failure], Tuberk Toraks, 54, 5 2004, Mycobacterium tuberculosis, Am J Transplant, 4, 37 Rothel, 2003, Comparison of tuberculosis tests: finding truth or confirming prejudice?, Clin Infect Dis, 36, 1206, 10.1086/374670 Pathan, 2001, Direct ex vivo analysis of antigen-specific IFN-gamma-secreting CD4 T cells in Mycobacterium tuberculosis-infected individuals: associations with clinical disease state and effect of treatment, J Immunol, 167, 5217, 10.4049/jimmunol.167.9.5217 Shams, 2001, Contribution of CD8(+) T cells to gamma interferon production in human tuberculosis, Infect Immun, 69, 3497, 10.1128/IAI.69.5.3497-3501.2001 Rooney, 1976, Further observations on tuberculin reactions in active tuberculosis, Am J Med, 60, 517, 10.1016/0002-9343(76)90718-X Hirsch, 1999, Depressed T-cell interferon-gamma responses in pulmonary tuberculosis: analysis of underlying mechanisms and modulation with therapy, J Infect Dis, 180, 2069, 10.1086/315114 Christopoulos, 2009, Risk factors for tuberculosis in dialysis patients: a prospective multi-center clinical trial, BMC Nephrol, 10, 36, 10.1186/1471-2369-10-36